Recon: How Trump and RFK Jr. could reshape healthcare; Moderna reports slower RSV vaccine sales but better-than-expected COVID vaccine revenue
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States